Facente Consulting is supporting the California Department of Public Health and various counties throughout the state with technical assistance to develop and deploy the Implementation Blueprint in support of California’s Integrated Statewide Strategic Plan for Addressing HIV, HCV, and STIs from 2022-2026.
Facente Consulting provided strategic and project management support to guide the San Francisco Health Improvement Partnership—a collective impact initiative dedicated to reducing health disparities in San Francisco—in developing, implementing, and evaluating its annual priorities and activities.
The World Health Organization hired Facente Consulting to lead a team of subject matter experts to (i) systematically review the use of HIV recency assays for public health surveillance and (ii) write an updated technical guidance document on assay use for use by countries around the world.
Facente Consulting project managed, promoted, facilitated, and produced a two-day virtual Drug User Health Symposium as part of NACCHO’s Overdose Prevention and Response Mentorship Program.
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.
Facente Consulting provided project management support that enabled the Rafiki Coalition to create a coalition of agencies designed to address disparities in COVID-19 testing, infection, and care for Blacks/African Americans in San Francisco.
The Rafiki Coalition hired Facente Consulting to provide program management and create and refine hiring solutions during a period of organizational transition.
The San Francisco Department of Public Health hired Facente Consulting to serve as a project manager for a pilot program to provide low-threshold buprenorphine via telemedicine to people living in San Francisco.
Facente Consulting is supporting the Santa Clara County Public Health Department in implementing International Overdose Awareness Day events in 2025 and 2026.
Dr. Facente served as the project manager for the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) for more than a decade, providing high-level project coordination and analytic support to researchers focused on HIV incidence estimation around the world.
Facente Consulting was hired during the formation of End Hep C SF to provide “backbone support” for this collective impact initiative, assist with strategic planning, and lead research and surveillance activities to monitor progress toward hepatitis C elimination.
Through an extensive stakeholder engagement process, Facente Consulting helped California’s Tobacco Prevention Program to develop an equity and justice framework for commercial tobacco prevention.
